These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30585845)

  • 1. HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa.
    Heffron R; Stalter R; Pyra M; Nanda K; Erikson DW; Hladik F; Blue SW; Davis NL; Mugo N; Kourtis AP; Lingappa JR; Baeten JM;
    AIDS; 2019 Mar; 33(4):735-744. PubMed ID: 30585845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.
    Nanda K; Callahan R; Taylor D; Wang M; Agot K; Jenkins D; Van Damme L; Dorflinger L;
    Contraception; 2016 Jul; 94(1):40-7. PubMed ID: 26972780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem in Chinese women.
    Zhou XF; Shao QX; Han XJ; Weng LJ; Sang GW
    Contraception; 1998 Jun; 57(6):405-11. PubMed ID: 9693401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women.
    Rahimy MH; Ryan KK
    Contraception; 1999 Oct; 60(4):189-200. PubMed ID: 10640165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): effects of body weight and injection sites on pharmacokinetics.
    Rahimy MH; Cromie MA; Hopkins NK; Tong DM
    Contraception; 1999 Oct; 60(4):201-8. PubMed ID: 10640166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Virutamasen P; Wangsuphachart S; Reinprayoon D; Kriengsinyot R; Leepipatpaiboon S; Gua C
    Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medroxyprogesterone acetate concentrations among HIV-infected depot-medroxyprogesterone acetate users receiving antiretroviral therapy in Lilongwe, Malawi.
    Zia Y; Tang JH; Chinula L; Tegha G; Stanczyk FZ; Kourtis AP
    Contraception; 2019 Nov; 100(5):402-405. PubMed ID: 31374188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
    Mngqibisa R; Kendall MA; Dooley K; Wu XS; Firnhaber C; Mcilleron H; Robinson J; Cramer Y; Rosenkranz SL; Roa J; Coughlin K; Mawlana S; Badal-Faesen S; Schnabel D; Omoz-Oarhe A; Samaneka W; Godfrey C; Cohn SE;
    Clin Infect Dis; 2020 Jul; 71(3):517-524. PubMed ID: 31504342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval.
    Smit J; Botha J; McFadyen L; Beksinska M
    Contraception; 2004 Jan; 69(1):3-7. PubMed ID: 14720612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.
    Boodhram R; Moodley D; Abbai N; Ramjee G
    BMC Womens Health; 2019 May; 19(1):63. PubMed ID: 31068152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women.
    Rahimy MH; Ryan KK; Hopkins NK
    Contraception; 1999 Oct; 60(4):209-14. PubMed ID: 10640167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.
    Pyra M; Lingappa JR; Heffron R; Erikson DW; Blue SW; Patel RC; Nanda K; Rees H; Mugo NR; Davis NL; Kourtis AP; Baeten JM;
    Contraception; 2018 Apr; 97(4):357-362. PubMed ID: 29408422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
    Ralph LJ; McCoy SI; Shiu K; Padian NS
    Lancet Infect Dis; 2015 Feb; 15(2):181-9. PubMed ID: 25578825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of depot medroxyprogesterone acetate contraception.
    Mishell DR
    J Reprod Med; 1996 May; 41(5 Suppl):381-90. PubMed ID: 8725700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
    mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Progestin Medroxyprogesterone Acetate Affects HIV-1 Production in Human Lymphoid Tissue Explants in a Dose-Dependent and Glucocorticoid-like Fashion.
    Vanpouille C; Günaydın G; Jangard M; Clerici M; Margolis L; Broliden K; Introini A
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications.
    Dutton C; Mody SK; Nippita S; Dodge LE; Pang T; Pennell PB; Davis A
    Contraception; 2024 Jun; 134():110418. PubMed ID: 38452921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.